Pfizer Expected to Pay $290,000 to Patients in Four States in Settlement
Pfizer has agreed to pay $290,000 to patients in Colorado, Vermont, Arizona and Kansas to settle allegations over alleged misleading copay coupons for four drugs.
The coupons concern the following drugs: menopause drug Estring (estradiol vaginal ring), the attention deficit hyperactivity disorder drugs Quillivant XR (methylphenidate hydrochloride) and Quillichew ER (methylphenidate hydrochloride), and pain medication Flector Patch (diclofenac epolamine).
In Colorado, for example, from 2014 through 2018, Pfizer’s “pay no more than” coupons contained small print terms and conditions listed that were not clear, making its residents pay more than they were legally obligated to pay for use of the drugs, the state alleged.
Under the terms of the settlement, the company does not admit to any wrongdoing.
May 24, 2022